On May 22, Simcere Pharma (02096) spent HKD 8.6963 million to repurchase 829,000 shares.
Sinopharm Holdings (02096) announced that it will spend HKD 8.6963 million to repurchase 829,000 shares on May 22, 2026.
SIMCERE PHARMA (02096) announced that it would spend 8.6963 million Hong Kong dollars to repurchase 829,000 shares on May 22, 2026.
Related Articles
FDB Holdings (01826): Leung Ka Man appointed as Independent Non-executive Director.
DALIPAL HLDG (01921) subsidiary entered into an EPC contract with MCC Jingcheng Engineering Technology.
Shenzhen Hepalink Pharmaceutical Group (09989) will distribute a final dividend of 1.6604 Hong Kong dollars per 10 shares on July 22nd.
FDB Holdings (01826): Leung Ka Man appointed as Independent Non-executive Director.
DALIPAL HLDG (01921) subsidiary entered into an EPC contract with MCC Jingcheng Engineering Technology.
Shenzhen Hepalink Pharmaceutical Group (09989) will distribute a final dividend of 1.6604 Hong Kong dollars per 10 shares on July 22nd.
